Global Pulmonary Arterial Hypertension Market Size & Outlook

The pulmonary arterial hypertension industry worldwide is expected to reach a projected revenue of US$ 10,609.4 million by 2030. A compound annual growth rate of 5.3% is expected of the worldwide pulmonary arterial hypertension industry from 2024 to 2030.
Revenue, 2023 (US$M)
$7,377.6
Forecast, 2030 (US$M)
$10,609.4
CAGR, 2024 - 2030
5.3%
Report Coverage
Worldwide

Global pulmonary arterial hypertension market, 2018-2030 (US$M)

Related Markets

Global pulmonary arterial hypertension market highlights

  • The global pulmonary arterial hypertension market generated a revenue of USD 7,377.6 million in 2023 and is expected to reach USD 10,609.4 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 5.3% by 2030.
  • In terms of segment, prostacyclin and prostacyclin analogs accounted for a revenue of USD 3,487.0 million in 2023.
  • SGC Stimulators is the most lucrative drug class segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.
  • Country-wise, Denmark is expected to register the highest CAGR from 2024 to 2030.


Global data book summary

Market revenue in 2023USD 7,377.6 million
Market revenue in 2030USD 10,609.4 million
Growth rate5.3% (CAGR from 2023 to 2030)
Largest segmentProstacyclin and prostacyclin analogs
Fastest growing segmentSGC Stimulators
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationEndothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors, Prostacyclin and Prostacyclin Analogs, SGC Stimulators


Other key industry trends

  • In terms of revenue, the North America accounted for 43.7% of the global pulmonary arterial hypertension market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Denmark is the fastest growing regional market and is projected to reach USD 78.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Pulmonary Arterial Hypertension Market Companies

Name Profile # Employees HQ Website

Global pulmonary arterial hypertension market size, by region, 2018-2030 (US$M)

Top 10 countries: Pulmonary arterial hypertension market size, 2023 (US$M)

Global pulmonary arterial hypertension market share, by drug class, 2023 & 2030 (%, US$M)

Pulmonary arterial hypertension market: Opportunity assessment by country

Global pulmonary arterial hypertension market, by region, 2023 (US$M)

Global pulmonary arterial hypertension market size, by region, 2018-2030 (US$M)

Drug Class 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR
North America 2,481.1 2,554.1 2,782.1 2,984.2 3,097.3 3,220.9 3,356.1 3,504.3 3,667.2 3,846.3 4,043.9 4,262.4 4,504.4 4.9%
Europe 1,546.8 1,592.7 1,735.2 1,861.7 1,932.7 2,010.2 2,095.1 2,188.1 2,290.2 2,402.6 2,526.6 2,663.7 2,815.6 4.9%
Asia Pacific 669.2 701.9 778.8 850.8 899.2 952.0 1,009.7 1,072.9 1,142.5 1,219.1 1,303.8 1,397.6 1,501.9 6.7%
Latin America 509.5 528.6 580.2 627.2 656.1 687.5 722.0 759.7 801.2 846.9 897.3 953.1 1,015.1 5.7%
MEA 366.6 382.2 421.7 458.1 481.5 507.0 534.9 565.4 599.1 636.0 676.9 722.2 772.4 6.2%
Overall 5,573.2 5,759.4 6,298.0 6,782.0 7,066.7 7,377.6 7,717.7 8,090.5 8,500.1 8,950.9 9,448.5 9,998.9 10,609.4 5.3%

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more